IDHC — Integrated Diagnostics Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
$221.10m
Enterprise Value
$236.68m
Revenue
EGP4.12bn

Annual income statement for Integrated Diagnostics Holdings, fiscal year end - December 31st, EGP millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,226	2,656	5,225	3,605	4,123
Cost of Revenue
Gross Profit	1,084	1,343	2,804	1,462	1,524
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,436	1,671	2,963	2,773	3,385
Operating Profit	791	986	2,262	832	738
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	758	969	2,232	854	737
Provision for Income Taxes
Net Income After Taxes	505	609	1,493	527	468
Minority Interest
Net Income Before Extraordinary Items
Net Income	511	594	1,413	541	510
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	511	594	1,413	541	510
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.852	0.99	2.35	0.925	0.901
Dividends per Share